RepliCel Life Sciences Inc.
REPCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7,000.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.01 |
| Beta | 0.56 |
| Outstanding Shares | 70,003,019 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -9.38 |
|---|---|
| PEG | 13 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About RepliCel Life Sciences Inc.
1 employees
CEO: Andrew Schutte
RepliCel Life Sciences Inc., a biotechnology firm based in Vancouver, Canada, specializes in regenerative medicine. The company focuses on developing patient-specific cell therapies designed to address functional cellular deficits. Their...